呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

2021 ATS临床实践指南：应用呼出气一氧化氮分数指导哮喘治疗

2021-11-15 美国胸科学会 Am J Respir Crit Care Med

哮喘治疗哮喘及肺康复呼出气一氧化氮分数

2021年11月，美国胸科学会(ATS)发布了应用呼出气一氧化氮分数指导哮喘治疗的临床实践指南。

中文标题：

2021 ATS临床实践指南：应用呼出气一氧化氮分数指导哮喘治疗

英文标题：

Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline

发布机构：

美国胸科学会

发布日期：

2021-11-15

简要介绍：

2021年11月，美国胸科学会(ATS)发布了应用呼出气一氧化氮分数指导哮喘治疗的临床实践指南。呼出气一氧化氮分数 (FENO)检测是用于评估哮喘的即时检验。本文主要针对FENO指导哮喘治疗的相关内容提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ATS临床实践指南：应用呼出气一氧化氮分数指导哮喘治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=433db1c00226a326, title=2021 ATS临床实践指南：应用呼出气一氧化氮分数指导哮喘治疗, enTitle=Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline, guiderFrom=Am J Respir Crit Care Med, authorId=0, author=, summary=2021年11月，美国胸科学会(ATS)发布了应用呼出气一氧化氮分数指导哮喘治疗的临床实践指南。, cover=https://img.medsci.cn/20211116/1637053421359_5579292.jpg, journalId=0, articlesId=null, associationId=181, associationName=美国胸科学会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Nov 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年11月，美国胸科学会(ATS)发布了应用呼出气一氧化氮分数指导哮喘治疗的临床实践指南。呼出气一氧化氮分数 (FE</span><sub style="color: #373737;">NO</sub><span style="color: #373737;">)检测是用于评估哮喘的即时检验。本文主要针对FENO指导哮喘治疗的相关内容提供指导建议。</span></p>, tagList=[TagDto(tagId=14843, tagName=哮喘治疗), TagDto(tagId=117807, tagName=哮喘及肺康复), TagDto(tagId=117808, tagName=呼出气一氧化氮分数)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=14843, guiderKeyword=哮喘治疗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2624, appHits=178, showAppHits=0, pcHits=463, showPcHits=2445, likes=0, shares=15, comments=13, approvalStatus=1, publishedTime=Wed Nov 17 00:08:30 CST 2021, publishedTimeString=2021-11-15, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=dajiong, createdTime=Tue Nov 16 17:58:11 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 14:12:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ATS临床实践指南：应用呼出气一氧化氮分数指导哮喘治疗.pdf)])
2021 ATS临床实践指南：应用呼出气一氧化氮分数指导哮喘治疗.pdf
下载请点击：
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1080495, encodeId=8a9e1080495cc, content=加强临床应用指导实践, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f8b6404591, createdName=ms1000002081782074, createdTime=Thu Dec 16 06:55:15 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078934, encodeId=c52f10e8934e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed506396921, createdName=ms8000000249558528, createdTime=Sat Dec 11 01:29:24 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078858, encodeId=777c10e8858aa, content=想看，没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d19f5585856, createdName=ms8000001852432672, createdTime=Fri Dec 10 19:44:51 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075627, encodeId=9fb610e5627b9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1075639860, createdName=ms2000000856104778, createdTime=Tue Nov 30 23:43:46 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074479, encodeId=f15610e447979, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/b436ec2680e649b9aab8fe9013f28b89/1c045bfba5b1429cba00b9bf54560d48.jpg, createdBy=c2492570261, createdName=12580979m36暂无昵称, createdTime=Sat Nov 27 13:01:17 CST 2021, time=2021-11-27, status=1, ipAttribution=)]
    2021-12-16 ms1000002081782074

    加强临床应用指导实践

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1080495, encodeId=8a9e1080495cc, content=加强临床应用指导实践, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f8b6404591, createdName=ms1000002081782074, createdTime=Thu Dec 16 06:55:15 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078934, encodeId=c52f10e8934e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed506396921, createdName=ms8000000249558528, createdTime=Sat Dec 11 01:29:24 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078858, encodeId=777c10e8858aa, content=想看，没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d19f5585856, createdName=ms8000001852432672, createdTime=Fri Dec 10 19:44:51 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075627, encodeId=9fb610e5627b9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1075639860, createdName=ms2000000856104778, createdTime=Tue Nov 30 23:43:46 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074479, encodeId=f15610e447979, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/b436ec2680e649b9aab8fe9013f28b89/1c045bfba5b1429cba00b9bf54560d48.jpg, createdBy=c2492570261, createdName=12580979m36暂无昵称, createdTime=Sat Nov 27 13:01:17 CST 2021, time=2021-11-27, status=1, ipAttribution=)]
    2021-12-11 ms8000000249558528

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1080495, encodeId=8a9e1080495cc, content=加强临床应用指导实践, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f8b6404591, createdName=ms1000002081782074, createdTime=Thu Dec 16 06:55:15 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078934, encodeId=c52f10e8934e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed506396921, createdName=ms8000000249558528, createdTime=Sat Dec 11 01:29:24 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078858, encodeId=777c10e8858aa, content=想看，没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d19f5585856, createdName=ms8000001852432672, createdTime=Fri Dec 10 19:44:51 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075627, encodeId=9fb610e5627b9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1075639860, createdName=ms2000000856104778, createdTime=Tue Nov 30 23:43:46 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074479, encodeId=f15610e447979, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/b436ec2680e649b9aab8fe9013f28b89/1c045bfba5b1429cba00b9bf54560d48.jpg, createdBy=c2492570261, createdName=12580979m36暂无昵称, createdTime=Sat Nov 27 13:01:17 CST 2021, time=2021-11-27, status=1, ipAttribution=)]
    2021-12-10 ms8000001852432672

    想看，没积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1080495, encodeId=8a9e1080495cc, content=加强临床应用指导实践, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f8b6404591, createdName=ms1000002081782074, createdTime=Thu Dec 16 06:55:15 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078934, encodeId=c52f10e8934e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed506396921, createdName=ms8000000249558528, createdTime=Sat Dec 11 01:29:24 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078858, encodeId=777c10e8858aa, content=想看，没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d19f5585856, createdName=ms8000001852432672, createdTime=Fri Dec 10 19:44:51 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075627, encodeId=9fb610e5627b9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1075639860, createdName=ms2000000856104778, createdTime=Tue Nov 30 23:43:46 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074479, encodeId=f15610e447979, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/b436ec2680e649b9aab8fe9013f28b89/1c045bfba5b1429cba00b9bf54560d48.jpg, createdBy=c2492570261, createdName=12580979m36暂无昵称, createdTime=Sat Nov 27 13:01:17 CST 2021, time=2021-11-27, status=1, ipAttribution=)]
    2021-11-30 ms2000000856104778

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1080495, encodeId=8a9e1080495cc, content=加强临床应用指导实践, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f8b6404591, createdName=ms1000002081782074, createdTime=Thu Dec 16 06:55:15 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078934, encodeId=c52f10e8934e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed506396921, createdName=ms8000000249558528, createdTime=Sat Dec 11 01:29:24 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078858, encodeId=777c10e8858aa, content=想看，没积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d19f5585856, createdName=ms8000001852432672, createdTime=Fri Dec 10 19:44:51 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075627, encodeId=9fb610e5627b9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1075639860, createdName=ms2000000856104778, createdTime=Tue Nov 30 23:43:46 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074479, encodeId=f15610e447979, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210521/b436ec2680e649b9aab8fe9013f28b89/1c045bfba5b1429cba00b9bf54560d48.jpg, createdBy=c2492570261, createdName=12580979m36暂无昵称, createdTime=Sat Nov 27 13:01:17 CST 2021, time=2021-11-27, status=1, ipAttribution=)]
    2021-11-27 12580979m36暂无昵称

    学习

    0

以上为热门评论，梅斯医学App还有更多内容